Articles

In vitro Effects of Propranolol on T Helper Type 1 Cytokine Profile in Human

Abstract

Introduction: Cytokines are a large group of proteins play a key role in inflammation. Down-regulation of pro-inflammatory cytokines has beneficial effect on heart function. Propranolol, as a non selective beta-adrenergic blocker, has been extensively used for treatment of many cardiovascular problems such as arrhythmias and heart malfunction. In addition anti-inflammatory effects of propranolol have been revealed. In this study the propranolol effect on T helper type 1 cytokine profile in human leukemic T cells has been assessed in vitro.
Materials and methods: Human leukemic T cells (Molt-4 and Jurkat) were cultured in complete RPMI medium. The cells were then incubated with different concentrations of propranolol (0.03- 30 µM) in the presence or absence of PHA (10 µg/ml) for 48 hours. The supernatants of cell culture media were collected and used for cytokines assay.
Results: Propranolol significantly decreased the T helper type 1 cytokine profile [Interleukin-2 (IL-2) and Interferon- γ (IFN-γ)] production in PHA stimulated Molt-4 and Jurkat cells, after 48 hour of incubation time, dose-dependently compared to untreated control cells.
Conclusion: Our data showed a dose dependent inhibitory effect of propranolol on the IL-2 and IFN-γ production in human leukemic Molt-4 and Jurkat cells. The anti- inflammatory effect of propranolol reported by other investigators may be in part due to its suppressive effect on production of inflammatory cytokines such as IL-2 and IFN-γ. So, propranolol along with its chronic long-term usage in cardiovascular problems may have potential implication in treatment of inflammatory-based disorders.

Sales-Campos H, de Souza PR, Basso PJ, et al. Aedes aegypti salivary gland extract ameliorates experimental inflammatory bowel disease. Int Immunopharmacol. 2015; 26(1):13-22.

Furuzawa-Carballeda J, Sánchez-Guerrero J, Betanzos JL, et al. Differential cytokine expression and regulatory cells in patients with primary and secondary Sjögren's syndrome. Scand J Immunol. 2014; 80(6):432-40.

Maney P, Owens JL. Interleukin polymorphisms in aggressive periodontitis: A literature review. J Indian Soc Periodontol. 2015; 19(2): 131–141.

Jeon US, Choi JP, Kim YS, et al. The enhanced expression of IL-17-secreting T cells during the early progression of atherosclerosis in Apo E-deficient mice fed on a western-type diet. Exp Mol Med. 2015 May 15; 47: e163.

Peterson D, Brenu EW, Gottschalk G, et al. Cytokines in the cerebrospinal fluids of patients with chronic fatigue syndrome/myalgic encephalomyelitis. Mediators Inflamm. 2015; 2015: 929720.

Tilib Shamoun S, Le Friec G, Spinner N, et al. Immune dysregulation in Alagille syndrome: A new feature of the evolving phenotype. Clin Res Hepatol Gastroenterol. 2015; 39(5):566-9.

Jaiswal P, Mohanakumar KP, Rajamma U. Serotonin mediated immunoregulation and neural functions: Complicity in the aetiology of autism spectrum disorders. Neurosci Biobehav Rev. 2015; 55: 413-31.

Katsuhara A, Fujiki F, Aoyama N, et al. Transduction of a novel HLA-DRB1*04:05-restricted, WT1-specific TCR gene into human CD4+ T cells confers killing activity against human leukemia cells. Anticancer Res. 2015; 35(3):1251-61.

Lee YS, Kim MS, Lee DH, et al. Luteolin 8-C-β-fucopyranoside down regulates IL-6 expression by inhibiting MAPKs and the NF-κB signaling pathway in human monocytic cells. Pharmacol Rep. 2015 Jun; 67(3):581-7.

Li N, Wang C, Jia L, et al. Heart regeneration, stem cells, and cytokines. Regen Med Res. 2014; 2(1):6.

Patel C, Deoghare S. Heart failure: Novel therapeutic approaches. 2015; 61(2): 101-108.

Akbar S, Alorainy MS. The current status of beta blockers' use in the management of hypertension. Saudi Med J. 2014; 35(11): 1307-17.

Freitas F, Estato V, Lessa MA, et al. Cardiac microvascular rarefaction in hyperthyroid rats is reversed by losartan, diltiazem, and propranolol. Fundam Clin Pharmacol. 2015; 29(1):31-40.

Xu L, Yu WK, Lin ZL, et al. Impact of β-adrenoceptor blockade on systemic inflammation and coagulation disturbances in rats with acute traumatic coagulopathy. Med Sci Monit. 2015 Feb 12; 21:468-76.

Hajighasemi F, Hajighasemi S. Effect of propranolol on angiogenic Factors in Human Hematopoietic Cell Lines in vitro. Iran Biomed J. 2009; 13: 223-8.

Zhou Y, Xu M, Zhang Y, et al. Effects of long-term application of metoprolol and propranolol in a rat model of smoking. Clin Exp Pharmacol Physiol. 2014; 41(9):708-15.

Seyedi S, Andalib A, Rezaei A, et al. The Effects of Isoproterenol and Propranolol on Cytokine Profile Secretion by Cultured Tumor-infiltrating Lymphocytes Derived from Colorectal Cancer Patients. Cell J. 2012; 13(4):281-9.

Asano K, Yoshimura S, Nakane A. Adipose tissue-derived mesenchymal stem cells attenuate staphylococcal enterotoxin A-induced toxic shock. Infect Immun. 2015; 83(9):3490-6.

Sarada S, Titto M, Himadri P, et al. Curcumin prophylaxis mitigates the incidence of hypobaric hypoxia-induced altered ion channels expression and impaired tight junction proteins integrity in rat brain. J Neuroinflammation. 2015 Jun 6; 12: 113.

Ebbinghaus M, Gajda M, Boettger MK, et al. The anti-inflammatory effects of sympathectomy in murine antigen-induced arthritis are associated with a reduction of Th1 and Th17 responses. Ann Rheum Dis. 2012; 71(2):253-61.

Rodrigues WF, Madeira MF, da Silva TA, et al. Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation. Br J Pharmacol. 2012; 165(7):2140-51.

Hanke ML, Powell ND, Stiner LM, et al. Beta adrenergic blockade decreases the immunomodulatory effects of social disruption stress. Brain Behav Immun. 2012; 26(7):1150-9.

Hajighasemi F, Mirshafiey A. In vitro sensitivity of leukemia cells to propranolol. J Clin Med Res. 2009; 1(3): 144-149.

Iii Colado-Velázquez J, Mailloux-Salinas P, Medina-Contreras J, et al. Effect of Serenoa Repens on Oxidative Stress, Inflammatory and Growth Factors in Obese Wistar Rats with Benign Prostatic Hyperplasia. Phytother Res. 2015; 29(10):1525-31.

Dutta K, Prasad P, Sinha D. Chronic low level arsenic exposure evokes inflammatory responses and DNA damage. Int J Hyg Environ Health. 2015; 218(6):564-74.

Wolf D, Zirlik A, Ley K. Beyond vascular inflammation-recent advances in understanding atherosclerosis. Cell Mol Life Sci. 2015; 72(20): 3853-69.

Dewachter C, Belhaj A, Rondelet B, et al. Myocardial inflammation in experimental acute right ventricular failure: Effects of prostacyclin therapy. J Heart Lung Transplant. 2015; 34(10): 1334-45.

Kim JH, Kim JM, Cho YZ, et al. Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension. Clin Mol Hepatol. 2014; 20(4): 376–383.

Ito H, Ando T, Ogiso H, et al. Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice. Cancer Immunol Immunother. 2015 Apr; 64(4):429-36.

Coelho M, Moz M, Correia G, et al. Anti proliferative effects of β-blockers on human colorectal cancer cells. Oncol Rep. 2015 May; 33(5):2513-20.

Hanusova V, Skalova L, Kralova V, et al. Potential anti-cancer drugs commonly used for other indications. Curr Cancer Drug Targets. 2015; 15(1):35-52.

Yin G, Tang D, Dai J, et al. Combination Efficacy of Astragalus membranaceus and Curcuma wenyujin at Different Stages of Tumor Progression in an Imageable Orthotopic Nude Mouse Model of Metastatic Human Ovarian Cancer Expressing Red Fluorescent Protein. Anticancer Res. 2015; 35(6):3193-207.

Solov'eva NI, Timoshenko OS, Kugaevskaia EV, et al. [Key enzymes of degradation and angiogenesis as a factor of tumor progression in squamous cell carcinoma of the cervix]. Bioorg Khim. 2014; 40(6):743-51. [Article in Russian]

Gao Y, Theng SS, Mah WC, et al. Silibinin down-regulates FAT10 and modulate TNF-α/IFN-γ-induced chromosomal instability and apoptosis sensitivity. Biol Open. 2015; 4(8): 961-9.

Files
IssueVol 10, No 2 (2016) QRcode
SectionArticles
Keywords
Propranolol Cytokines Leukemic T-cells

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Hajighasemi F, Mirshafiey A. In vitro Effects of Propranolol on T Helper Type 1 Cytokine Profile in Human. Int J Hematol Oncol Stem Cell Res. 2016;10(2):99-105.